Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1β plasma levels

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Feng, Jinong ^a   Zhang, Zhifang ^a   Li, Wenyan ^a   Shen, Xiaoming ^a   Song, Wenjia ^a   Yang, Chunmei ^a   Chang, Frances ^a   Longmate, Jeffrey ^a   Marek, Claudia ^b   Paul St Amand, R ^b   Krontiris, Theodore G ^a   Shively, John E ^a   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Fibromyalgia Treatment Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; PROTEIN; PYRIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILIAL MEDITERRANEAN FEVER; FEVER; FIBROMYALGIA; GENE FUNCTION; GENE SEQUENCE; GENOTYPE; HETEROZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MYALGIA; PARENT; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 77954047346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008480     Document Type: Article

References (58)

1. Wolfe F, Cathey MA (1990) Assessment of functional ability in patients with fibromyalgia. Arch Intern Med 150: 460.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19-28.
3. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172.
4. Buskila D, Neumann L (1997) Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 24: 941-944.
5. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50: 944-952.
6. Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54: 1682-1686.
7. Buskila D, Neumann L, Hazanov I, Carmi R (1996) Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26: 605-611.
8. Crofford LJ (2008) Pain management in fibromyalgia. Curr Opin Rheumatol 20: 246-250.
9. Arnold LM (2007) Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 8 Suppl 2: S63-74.
10. Schwarz MJ, Offenbaecher M, Neumeister A, Ackenheil M (2003) Experimental evaluation of an altered tryptophan metabolism in fibromyalgia. Adv Exp Med Biol 527: 265-275.
11. Cohen H, Buskila D, Neumann L, Ebstein RP (2002) Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 46: 845-847.
12. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, et al. (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42: 2482-2488.
13. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, et al. (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6: 433-439.
14. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B (2001) Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 21: 58-61.
15. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, et al. (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23: 104-107.
16. Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9: 730-731.
17. Buskila D, Sarzi-Puttini P, Ablin JN (2007) The genetics of fibromyalgia syndrome. Pharmacogenomics 8: 67-74.
18. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, et al. (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233: 1171-1180.
19. Buskila D, Atzeni F, Sarzi-Puttini P (2008) Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev 8: 41-43.
20. Baio P, Brucato A, Buskila D, Gershwin ME, Giacomazzi D, et al. (2008) Autoimmune diseases and infections: controversial issues. Clin Exp Rheumatol 26: S74-80.
21. Ablin J, Neumann L, Buskila D (2008) Pathogenesis of fibromyalgia - a review. Joint Bone Spine 75: 273-279.
22. Sprott H, Salemi S, Gay RE, Bradley LA, Alarcon GS, et al. (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63: 245-251.
23. Pace F, Zuin G, Di Giacomo S, Molteni P, Casini V, et al. (2006) Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain. World J Gastroenterol 12: 3874-3877.
24. Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, et al. (1999) Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 94: 3541-3546.
25. Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18: 108-117.
26. Onen F (2006) Familial Mediterranean fever. Rheumatol Int 26: 489-496.
27. Franchi L, Warner N, Viani K, Nunez G (2009) Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 227: 106-128.
28. Mathews RJ, Sprakes MB, McDermott MF (2008) NOD-like receptors and inflammation. Arthritis Res Ther 10: 228.
29. Chen G, Shaw MH, Kim YG, Nunez G (2008) Nod-like Receptors: Role in Innate Immunity and Inflammatory Disease. Annu Rev Pathol.
30. Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20: 3-9.
31. Stehlik C (2007) The PYRIN domain in signal transduction. Curr Protein Pept Sci 8: 293-310.
32. Shinkai K, Kilcline C, Connolly MK, Frieden IJ (2005) The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease. Arch Dermatol 141: 242-247.
33. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G (2009) The inflamma- some: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247.
34. Saito M, Nishikomori R, Kambe N, Fujisawa A, Tanizaki H, et al. (2008) Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome pa- tients. Blood 111: 2132-2141.
35. Dinarello CA (2007) Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity. Arthritis Rheum 56: 2817-2822.
36. Aksentijevich I, C DP, Remmers EF, Mueller JL, Le J, et al. (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 56: 1273-1285.
37. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
38. Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, et al. (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103: 2809-2815.
39. Berkun Y, Ben-Chetrit E (2007) Pyrin and cryopyrin-similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol 25: S6-8.
40. Strober W, Kitani A, Fuss I, Asano N, Watanabe T (2008) The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol 1 Suppl 1: S5-9.
41. Watanabe T, Kitani A, Strober W (2005) NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut 54: 1515-1518.
42. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, et al. (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057-1060.
43. Kryukov GV, Pennacchio LA, Sunyaev SR (2007) Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 80: 727-739.
44. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, et al. (1998) Non- founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7: 1317-1325.
45. Locati M, Murphy PM (1999) Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 50: 425-440.
46. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
47. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, et al. (1999) MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65: 88-97.
48. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, et al. (2007) MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 71: 458-467.
49. Ritis K, Giaglis S, Spathari N, Micheli A, Zonios D, et al. (2004) Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients. Ann Rheum Dis 63: 438-443.
50. McCarthy MI (2009) Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery. Oxford: University of Oxford.
51. Pritchard JK (2001) Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69: 124-137.
52. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212-219.
53. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.
54. Slager SL, Huang J, Vieland VJ (2000) Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol 18: 143-156.
55. Gavrilin MA, Deucher MF, Boeckman F, Kolattukudy PE (2000) Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. Biochem Biophys Res Commun 277: 37-42.
56. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97: 1920-1924.
57. Sun JH, Yang B, Donnelly DF, Ma C, LaMotte RH (2006) MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol 96: 2189-2199.
58. Sell H, Dietze-Schroeder D, Kaiser U, Eckel J (2006) Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147: 2458-2467.